Pharmacists in Verona, NJ Accepting Medicare
8 Pharmacists found. Showing 1 - 8
 Mr. Benedict Dephillips, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Vincent Pl, Verona, NJ 07044 Phone: 973-255-6858 |
Dr. Sandeep R Patel, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Claremont Ave, Verona, NJ 07044 Phone: 973-559-0901 |
 Dr. Margurite Morcos Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Claremont Ave, Verona, NJ 07044 Phone: 973-559-0901 |
Kirti K Kathwadia, DR. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Claremont Ave, Verona, NJ 07044 Phone: 973-559-0901 |
Dr. Sandra Aziz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Claremont Ave, Verona, NJ 07044 Phone: 973-559-0901 |
Dr. Evin Alkilani, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Claremont Ave, Verona, NJ 07044 Phone: 973-559-0901 |
Mr. Ira L. Bornstein, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 33 Brentwood Dr, Verona, NJ 07044 Phone: 201-998-8787 |
Mr. Vladimir Nastoski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 342 Claremont Ave, Verona, NJ 07044 Phone: 973-559-0901 Fax: 973-559-0903 |
News Archive
Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Rush's AARTS program to improve quality of life of children and adults with autism
The Chicago region's first comprehensive center serving patients from childhood into young adulthood with autism spectrum disorders has been established at Rush University Medical Center.
NKF 2010 Spring Clinical Meeting: Multiple posters on Hematide/peginesatide to be presented
Affymax, Inc. and Takeda Pharmaceuticals Global Research & Development Center, Inc., U.S., today announced multiple posters on Hematide™/peginesatide have been accepted for presentation at the National Kidney Foundation (NKF) 2010 Spring Clinical Meeting taking place April 13-17, 2010 in Orlando, Florida. Hematide is an investigational agent for the treatment of anemia in chronic renal failure (also referred to as renal anemia).
KeyLemon, onefacein team up to provide affordable and effective biometric solutions
Biometry authentication provider KeyLemon today announced a strategic partnership with emerging biometric password solution onefacein.
› Verified 9 days ago
Clinical Social Workers
Psychologists
Counselors
Dentists
Pharmacists
Marriage Counselors
Occupational Therapists